any planning the company does at the moment has to be based on the assumption that the trial outcome will be successful.
I am sure that whatever agreement they have set up will be set up in such a way that costs are minimised in the instance that the trial outcome isn't as good as hoped.
Ann: Factor Therapeutics Appoints Transaction Advisor, page-4
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
